Opko Health, Inc. (OPK)
-NYSE 6.97
0.08(1.16%) 4:04PM EDT|After Hours
:
6.96
0.01 (0.19%) 5:20PM EDT
| Prev Close: | 6.89 |
|---|
| Open: | 6.80 |
|---|
| Bid: | 6.90 x 200 |
|---|
| Ask: | 7.10 x 4000 |
|---|
| 1y Target Est: | 8.33 |
|---|
| Beta: | 1.28 |
|---|
| Next Earnings Date: | 5-Aug-13 |
|---|
| Day's Range: | 6.72 - 7.04 |
|---|
| 52wk Range: | 4.00 - 7.83 |
|---|
| Volume: | 982,304 |
|---|
| Avg Vol (3m): | 1,787,550 |
|---|
| Market Cap: | 2.35B |
|---|
| P/E (ttm): | N/A |
|---|
| EPS (ttm): | -0.19 |
|---|
| Div & Yield: | N/A (N/A) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- 5 Big Stocks That Could Drop in Mayat TheStreet(Thu 11:50AM EDT)
- InPlay: Opko Health surpasses 50% enrollment in first Phase 3 trial of Rayaldy (CTAP101 capsules)Briefing.com(Thu 9:35AM EDT)
- OPKO Health surpasses 50% enrollment in first Phase 3 trial of Rayaldyat theflyonthewall.com(Thu 9:35AM EDT)
- OPKO Surpasses 50% Enrollment in First Phase 3 Trial of RayaldyTM (CTAP101 Capsules)Business Wire(Thu 9:32AM EDT)
- Opko Health CEO Buys More Than 73K Shares and 4 Insider Trades to Noteat Wall St. Cheat Sheet(Thu 8:37AM EDT)
- Royce Focus Trust VP Buys More Than 94K Shares and 4 Insider Trades to Noteat Wall St. Cheat Sheet(Wed, May 22)
- Prolor Biotech Buyout: Is The Opko Bear Case Now Dead?at Seeking Alpha(Wed, May 22)
- MoSys CEO Buys 250K Shares and 4 Insider Trades to Noteat Wall St. Cheat Sheet(Tue, May 21)
- Interesting OPK Put And Call For Julyat TheStreet(Mon, May 20)
- OPKO HEALTH, INC. FinancialsEDGAR Online Financials(Fri, May 17)
- American Shared Hospital Director Buys 50K Shares and 4 Insider Trades to Noteat Wall St. Cheat Sheet(Fri, May 17)
- Billionaire Frost Props Up Prolor Bid With Stock Buysat Bloomberg(Thu, May 16)
- Lionbridge Part-Owner Buys 69K Shares and 4 Insider Trades to Noteat Wall St. Cheat Sheet(Thu, May 16)
- Cramer Says Sell PennyMac, But Buy Opko Health, Pinnacle Foods, and This Stockat Wall St. Cheat Sheet(Wed, May 15)
- Opko Health CEO Buys More Than 46K Shares and 4 Insider Trades to Noteat Wall St. Cheat Sheet(Wed, May 15)
Key Statistics
| Forward P/E (1 yr): | N/A |
|---|
| P/S (ttm): | 33.31 |
|---|
| Ex-Dividend Date: | N/A |
|---|
Analysts
| Annual EPS Est
(Dec-13)
: | -0.21 |
|---|
| Quarterly EPS Est
(Jun-13)
: | -0.05 |
|---|
| Mean Recommendation*: | 1.0 |
|---|
| PEG Ratio (5 yr expected): | N/A |
|---|
Business Summary
Opko Health, Inc., a pharmaceutical and diagnostics company, engages in the discovery, development, and commercialization of novel and proprietary technologies.
View More